• Publications
  • Influence
A Double-Blind Randomised Placebo-Controlled Evaluation of Three Doses of Botulinum Toxin Type A (Dysport®) in the Treatment of Spastic Equinovarus Deformity after Stroke
Background/Objectives: Calf muscle hypertonicity following stroke may impair walking rehabilitation. The aim of this study was to assess botulinum toxin (Dysport®) in post-stroke calf spasticity.Expand
  • 197
  • 9
Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm
Botulinum neurotoxins (BoNTs) are the primary treatment for focal dystonias such as blepharospasm. Several different BoNT products are available in various countries. Given the variability inExpand
  • 63
  • 4
Effects of Treatment With the Antioxidant α-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients: A 4-month randomized controlled multicenter trial (DEKAN Study)
OBJECTIVE To evaluate the efficacy and safety of oral treatment with the antioxidant alpha-lipoic acid (ALA) in NIDDM patients with cardiac autonomic neuropathy (CAN), assessed by heart rateExpand
  • 215
  • 2
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale
OBJECTIVE To evaluate the efficacy and safety of oral treatment with the antioxidant alpha-lipoic acid (ALA) in NIDDM patients with cardiac autonomic neuropathy (CAN), assessed by heart rateExpand
  • 99
  • 2
Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport<ce:sup loc=post>®</ce:sup>) for the relief of upper back myofascial pain syndrome: Results from a randomized
&NA; Botulinum type A toxin (BoNT‐A) has antinociceptive and muscle‐relaxant properties and may help relieve the symptoms of myofascial pain syndrome. In this study we evaluated the efficacy andExpand
  • 139
  • 2
Current clinical applications of botulinum toxin.
Botulinum toxin has long been known for its paralytic effects on the human voluntary musculature via inhibition of acetylcholine release at neuromuscular junctions. Its original clinical use for theExpand
  • 39
  • 2
Botulinum toxin for treatment of spasticity in adults
  • G. Reichel
  • Medicine
  • Journal of Neurology
  • 10 April 2001
Abstract Although a few hundred papers have been published on the treatment of adult spasticity with botulinum toxin, the number of randomized placebo-controlled double-blind studies, by comparison,Expand
  • 30
  • 2
An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)
Objectives It remains to be determined whether the benefits of botulinum toxin type A (BoNT-A) on cervical dystonia (CD) motor symptoms extend to improvements in patient's quality of life (QoL). ThisExpand
  • 30
  • 2
  • PDF
Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift
OBJECTIVES Anterocollis as a rare subtype of cervical dystonia is difficult to treat and thus less appreciated than other subtypes of cervical dystonia. This review aimed at summarising andExpand
  • 12
  • 2
[Effect of botulinum toxin a and B on vegetative cardiac innervation].
The objective of this study was to examine whether vegetative cardiac innervation is affected by local application of botulinum toxin A and B. For that purpose, heart rate variability (HRV) wasExpand
  • 7
  • 2
...
1
2
3
4
5
...